These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23715201)

  • 1. Evaluation of ozonated olive oil with or without adjunctive application of calcium sodium phosphosilicate on post-surgical root dentin hypersensitivity: a randomized, double-blinded, controlled, clinical trial.
    Patel PV; Patel A; Kumar S; Holmes JC
    Minerva Stomatol; 2013 May; 62(5):147-61. PubMed ID: 23715201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of subgingival application of topical ozonated olive oil in the treatment of chronic periodontitis: a randomized, controlled, double blind, clinical and microbiological study.
    Patel PV; Patel A; Kumar S; Holmes JC
    Minerva Stomatol; 2012 Sep; 61(9):381-98. PubMed ID: 22976566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical efficacy of a dentifrice containing calcium sodium phosphosilicate to a dentifrice containing potassium nitrate and to a placebo on dentinal hypersensitivity: a randomized clinical trial.
    Pradeep AR; Sharma A
    J Periodontol; 2010 Aug; 81(8):1167-73. PubMed ID: 20370417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of a dentifrice containing calcium sodium phosphosilicate (novamin) for the treatment of dentin hypersensitivity.
    Du Min Q; Bian Z; Jiang H; Greenspan DC; Burwell AK; Zhong J; Tai BJ
    Am J Dent; 2008 Aug; 21(4):210-4. PubMed ID: 18795515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of two treatment regimens combining in-office and at-home programs for dentin hypersensitivity relief: a 24-week clinical study.
    Hamlin D; Mateo LR; Dibart S; Delgado E; Zhang YP; DeVizio W
    Am J Dent; 2012 Jun; 25(3):146-52. PubMed ID: 22988684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative in vitro study investigating the occlusion and mineralization properties of commercial toothpastes in a four-day dentin disc model.
    Parkinson CR; Willson RJ
    J Clin Dent; 2011; 22(3):74-81. PubMed ID: 21905401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the efficacy in providing instant relief of dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a benchmark desensitizing toothpaste containing 2% potassium ion and 1450 ppm fluoride, and to a control toothpaste with 1450 ppm fluoride: a three-day clinical study in Mississauga, Canada.
    Ayad F; Ayad N; Delgado E; Zhang YP; DeVizio W; Cummins D; Mateo LR
    J Clin Dent; 2009; 20(4):115-22. PubMed ID: 19831164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy in reducing dentin hypersensitivity of a dentifrice containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride compared to a dentifrice containing 8% strontium acetate and 1040 ppm fluoride under consumer usage conditions before and after switch-over.
    Schiff T; Mateo LR; Delgado E; Cummins D; Zhang YP; DeVizio W
    J Clin Dent; 2011; 22(4):128-38. PubMed ID: 22403989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy of a 5% calcium sodium phosphosilicate (Novamin) containing dentifrice for the relief of dentinal hypersensitivity: a clinical study.
    Rajesh KS; Hedge S; Arun Kumar MS; Shetty DG
    Indian J Dent Res; 2012; 23(3):363-7. PubMed ID: 23059574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical efficacy of three toothpastes in reducing dentin hypersensitivity.
    Li Y; Lee S; Zhang YP; Delgado E; DeVizio W; Mateo LR
    J Clin Dent; 2011; 22(4):113-20. PubMed ID: 22403987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative clinical study investigating the efficacy of a test dentifrice containing 8% strontium acetate and 1040 ppm sodium fluoride versus a marketed control dentifrice containing 8% arginine, calcium carbonate, and 1450 ppm sodium monofluorophosphate in reducing dentinal hypersensitivity.
    Hughes N; Mason S; Jeffery P; Welton H; Tobin M; O'Shea C; Browne M
    J Clin Dent; 2010; 21(2):49-55. PubMed ID: 20669816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the clinical evidence for the use of NovaMin in providing relief from the pain of dentin hypersensitivity.
    Gendreau L; Barlow AP; Mason SC
    J Clin Dent; 2011; 22(3):90-5. PubMed ID: 21905403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical study of the effect of calcium sodium phosphosilicate on dentin hypersensitivity--proof of principle.
    Litkowski L; Greenspan DC
    J Clin Dent; 2010; 21(3):77-81. PubMed ID: 21207918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an in situ methodology for the clinical evaluation of dentine hypersensitivity occlusion ingredients.
    Claydon NC; Addy M; MacDonald EL; West NX; Maggio B; Barlow A; Parkinson C; Butler A
    J Clin Dent; 2009; 20(5):158-66. PubMed ID: 19902640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinical efficacy of a new dentifrice containing 8.0% arginine, calcium carbonate, and 1000 ppm fluoride to a commercially available sensitive toothpaste containing 2% potassium ion on dentin hypersensitivity: a randomized clinical trial.
    Kakar A; Kakar K; Sreenivasan PK; DeVizio W; Kohli R
    J Clin Dent; 2012; 23(2):40-7. PubMed ID: 22779216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomimetic mineralization: long-term observations in patients with dentin sensitivity.
    Guentsch A; Seidler K; Nietzsche S; Hefti AF; Preshaw PM; Watts DC; Jandt KD; Sigusch BW
    Dent Mater; 2012 Apr; 28(4):457-64. PubMed ID: 22305715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytological assessment of healing palatal donor site wounds and grafted gingival wounds after application of ozonated oil: an eighteen-month randomized controlled clinical trial.
    Patel PV; Kumar S; Vidya GD; Patel A; Holmes JC; Kumar V
    Acta Cytol; 2012; 56(3):277-84. PubMed ID: 22555530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical study comparing oral formulations containing 7.5% calcium sodium phosphosilicate (NovaMin), 5% potassium nitrate, and 0.4% stannous fluoride for the management of dentin hypersensitivity.
    Sharma N; Roy S; Kakar A; Greenspan DC; Scott R
    J Clin Dent; 2010; 21(3):88-92. PubMed ID: 21207920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the clinical efficacy in reducing dentin hypersensitivity of a new dentifrice containing 8.0% arginine, calcium carbonate, and 1000 ppm sodium monofluorophosphate to a commercially available toothpaste containing 1000 ppm sodium monofluorophosphate: an eight-week clinical trial on adults in New Delhi, India.
    Kakar A; Kakar K; Sreenivasan PK; DeVizio W; Kohli R
    J Clin Dent; 2012; 23(2):33-9. PubMed ID: 22779215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the efficacy in reducing dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a benchmark commercial desensitizing toothpaste containing 2% potassium ion: an eight-week clinical study in Rome, Italy.
    Docimo R; Montesani L; Maturo P; Costacurta M; Bartolino M; Zhang YP; DeVizio W; Delgado E; Cummins D; Dibart S; Mateo LR
    J Clin Dent; 2009; 20(4):137-43. PubMed ID: 19831167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.